ResMed Inc (RMD)
NYSE • Healthcare
May 20, 2026 at 16:00 UTC
About ResMed Inc
ResMed Inc is a medical technology company focused on sleep and respiratory care, pairing devices and software with programs that help patients stay on therapy. The business works where home care meets clinical oversight: equipment is designed for comfort and consistency, data flows to caregivers through secure channels, and support helps people manage therapy without turning it into a project. Providers use connected workflows to onboard patients, monitor adherence, and coordinate service visits in measured steps rather than emergency bursts. The operating principle is calm reliability — make equipment easy to live with, keep information clear for clinicians, and resolve issues quickly. Within healthcare, ResMed occupies the connective layer between prescription and daily use, helping long-term therapies fit ordinary routines.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ResMed Inc's Technical Indicators Summary
ResMed shows a bearish tilt as medium- and longer-term moving averages lie above the current price, indicating broader downward pressure despite short-term moving-average support. ADX is elevated, signaling a meaningful trend to the downside, and volume measures are negative which reinforces distribution. Momentum is soft with a negative MACD and muted RSI, while volatility is moderate. The classic pivot is below the market and may offer short-term reference, but overall technicals favor sellers. Technical takeaway: Bearish — stronger downtrend on medium/long horizons despite brief short-term support.
| Indicator | Value |
|---|---|
RSI (14) | 43.41 |
Stochastic %K (14, 3, 3) | 33.34 |
CCI (20) | -36.96 |
WPR (14) | -44.53 |
Momentum (10) | -0.10 |
MFI | 49.96 |
MACD Level (12, 26) | -5.80 |
Bollinger Bands | $195.30 - $224.01 |
ATR (14) | $5.56 (2.68%) |
ADX (14) | 37.27 |
OBV | -12,471,256 |
Classic Pivot Point | $203.30 |
Fibonacci Pivot Point | $203.30 |
Simple Moving Averages | $204.45 - $251.82(5 indicators) |
Exponential Moving Averages | $205.60 - $244.36(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Into the close, RMD still reflected a gentle 1.01% gap from yesterday, ending the session at 209.88. The day closed with RMD's options tilted bullish, as the put/call ratio settled around 0.54. RMD edges higher on upbeat quarterly results, with strong demand for devices and cloud software and a bullish options tilt.
Price Change
from $209.93 close
-$0.13
Trading Volume
Above avg 1.3M
1.3M
vs S&P 500 Today
Outperforming Market
+1.05%
52-Week Position
Lower range
11.8%
Updated: May 20, 2026 at 20:04 UTC
Quote Summary
RMD Headlines
RTX, P&G and ResMed in Focus After New Updates
April 20, 2026
Institutions Shift Positions in Major Blue-Chip Stocks
April 17, 2026
2025 Valuation Insights: Spotify, Aker BP, and Key Growth Stocks
December 7, 2025